Latest news with #KenvueInc
Yahoo
19 hours ago
- Business
- Yahoo
Kenvue's Q2 2025 Earnings: What to Expect
Skillman, New Jersey-based Kenvue Inc. (KVUE) operates as a global consumer health company. Valued at $41.9 billion by market cap, the company offers a consumer health portfolio in self-care, skin health & beauty, and essential health products. The world's largest pure-play consumer health company is expected to announce its fiscal second-quarter earnings for 2025 on Tuesday, Aug. 5. Ahead of the event, analysts expect KVUE to report a profit of $0.28 per share on a diluted basis, down 12.5% from $0.32 per share in the year-ago quarter. The company beat or matched the consensus estimate in each of the last four quarters. Dear Nvidia Stock Fans, Mark Your Calendars for July 16 How to Buy Tesla for a 13% Discount, or Achieve a 26% Annual Return Retirement Ready: 3 Dividend Stocks to Set and Forget Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! For the full year, analysts expect KVUE to report EPS of $1.12, down 1.8% from $1.14 in fiscal 2024. However, its EPS is expected to rise 8.9% year over year to $1.22 in fiscal 2026. KVUE stock has outperformed the S&P 500 Index's ($SPX) 10.9% gains over the past 52 weeks, with shares up 18.1% during this period. Similarly, it outperformed the Consumer Staples Select Sector SPDR Fund's (XLP) 4% gains over the same time frame. On May 8, KVUE shares closed up more than 4% after reporting its Q1 results. Its adjusted EPS of $0.24 topped Wall Street expectations of $0.22. The company's revenue was $3.74 billion, topping Wall Street forecasts of $3.68 billion. Analysts' consensus opinion on KVUE stock is reasonably bullish, with a 'Moderate Buy' rating overall. Out of 15 analysts covering the stock, five advise a 'Strong Buy' rating, and 10 give a 'Hold.' KVUE's average analyst price target is $24.50, indicating a potential upside of 14.5% from the current levels. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
Kenvue Inc. (KVUE) Has 'Good Brands,' Says Jim Cramer
We recently published . Kenvue Inc. (NYSE:KVUE) is one of the stocks Jim Cramer recently discussed. Kenvue Inc. (NYSE:KVUE) is a consumer goods company whose shares are flat year-to-date. Since the start of June, its shares have lost 9.8% after its CEO warned that consumers were pulling back on spending, which could lead to slow second-quarter sales. However, July 14th turned out to be a great day for the shares as they gained 5.4% in premarket after the firm announced that its CEO would leave. Cramer's remarks were made on Friday, and he maintained that Kenvue Inc. (NYSE:KVUE) has some great brands that it can leverage for better sales: 'It's down like 20 bucks now. . .they're not doing as well as I'd like. The CNBC host discussed Kenvue Inc. (NYSE:KVUE) in detail in March. Here's what he said: 'I am more in favor of Kenvue than I was yesterday, David. Appreciate you coming in early to do that one. But no, this is a good example.' A pharmacist at a local store, stocking shelves with products from the consumer health company. 'Don't you think that there is a belief with adjustment that there's not a lot of urgency here. That they've kind of been taking their time at the same time this could be a tremendous consolidator of all these companies that have been spun off that really all have their own boards and the administrative stuff. You really don't want that. When you're selling into Amazon, direct-to-consumer, you're selling into clubs, that's where you sell this stuff. Now Larry Merlo, chairman of the board, he comes from CVS, but he is there. I thought that both Hofstetter and Mann, sounded like total hitters. . . And I have more respect for Jeff Smith than, I mean Jeff Smith will come on the board with a real plan. And I think if they don't go with the plan, I think that there could be a change . . .' While we acknowledge the potential of KVUE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Mid East Info
07-07-2025
- Business
- Mid East Info
Kenvue Releases Second Annual Healthy Lives Mission Report Highlighting Progress in Reducing Emissions and Advancing More Sustainable Product Innovation
Company reports reduction of operational emissions by 37%, expanded use of renewable electricity to 72% and launch of multiple packaging innovations across portfolio Kenvue Inc. NYSE: KVUE, maker of iconic brands such as Neutrogena®, Listerine®, Aveeno®, and Tylenol® , today released its second Healthy Lives Mission Report. The report shares how Kenvue has helped advance the well-being of both people and planet in 2024, with progress noted across three pillars: Healthy People, Healthy Planet, and Healthy Practice. 'Having some of the most recognizable consumer brands in the world gives us a tremendous opportunity to create a positive impact for the millions of people we touch every day,' said Thibaut Mongon, Chief Executive Officer, Kenvue. 'Whether improving our packaging to be more sustainable, advancing the decarbonization of our operations, or giving back to our communities, our sustainability strategy is helping meet customer and consumer expectations, and deliver everyday care for generations to come.' Since becoming an independent company in 2023, Kenvue has invested in research and development, hired experts in areas like packaging, embedded sustainability into key functions and designed a sustainability strategy purposefully built to meet critical commitments and deliver superior consumer experiences and products. Highlights from the report include: Healthy People: Nicorette® QuickMist became the first nicotine replacement therapy (NRT) in the U.K. to be licensed to help vapers quit, with this vaping cessation indication now included across the whole Nicorette® range in the U.K. Helped train health care professionals (HCPs) in Malaysia on the use of NRT solutions like Nicorette® and worked with the Health Minister of Malaysia to launch its Cik Era (Miss Era) AI chatbot on the JomQuit (Come On, Quit) website, which offers smokers personalized support and advice on quitting smoking. Trained more than 7,000 Walgreen's pharmacists and 12,000 beauty consultants since 2020 through a collaboration between Neutrogena® and the Melanoma Research Foundation (MRF) on the importance of recommending sunscreen to consumers. Addressed women's health by destigmatizing conversations about menstruation in India led by Stayfree®, and menopause in the U.S with the launch of Versalie™, a digital platform dedicated to menopause and women's hormonal wellness. Launched health initiative in India to help reduce diarrhoea-related mortality and improve healthcare outcomes with an aim to reach approximately 5 million children under the age of five over the next two years. Kenvue donated more than $56 million to support communities in need. Healthy Planet: Reduced Scope 1 and 2 emissions 1,2,3 by 37% from a 2020 base year, toward a 42% reduction goal by 2030 4 . by 37% from a 2020 base year, toward a 42% reduction goal by 2030 . Expanded the use of renewable electricity 5 to 72% across global operations, with Latin America maintaining 100% renewable electricity 5 since 2023. to 72% across global operations, with Latin America maintaining 100% renewable electricity since 2023. Transitioned 69% of packaging 6 across portfolios to be recyclable 7 or refillable 8 , with a goal of 100% by 2025 4 . across portfolios to be recyclable or refillable , with a goal of 100% by 2025 . Reduced the use of virgin plastic 9 in packaging 6 by more than 21.4% from a 2020 base year, with goals of 25% by 2025 4 and 50% by 2030 4 . in packaging by more than 21.4% from a 2020 base year, with goals of 25% by 2025 and 50% by 2030 . Several Kenvue brands have contributed to this progress with redesigned packaging: Zyrtec® switched from plastic blister packs to paper, saving more than 1,520,000 pounds of plastic annually. Johnson's® Baby in Latin America launched shampoo and bath products in refillable, recycle-ready pouches. Dabao® in China made their plastic bottles lighter, saving over 264,000 pounds of plastic. Healthy Practice: Integrated sustainability into research and development with the launch of the Sustainable Innovation Profiler, a patent-pending tool designed to measure a product's environmental performance and enable developers to make real-time choices to design solutions that benefit both people and the planet. This tool is now embedded in Kenvue's product development process across R&D. The tool, already operational, helped inform design solutions to improve the packaging performance for several products including: OGX® Argan Oil Shampoo and Conditioner bottles: Redesigned to address consumer feedback, including improved 'squeezability', a reduced product environmental impact and total carbon footprint, and improved green chemistry and packaging with a fully recyclable, 100% Post-Consumer Recycled High-Density Polyethylene (PCR HDPE) bottle. Nicorette® Icy Mint Lozenge: Revamped its primary packaging, reducing plastic waste by 85% and reducing the product's total carbon footprint by 17%, compared to the previous version. About Kenvue: Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Cautions Concerning Forward-Looking Statements: This media alert contains 'forward-looking statements' as defined in the Private Securities Litigation Reform Act of 1995, including forward-looking statements related to the Healthy Lives Mission and its related goals and commitments. Forward-looking statements may be identified by the use of words such as 'plans, 'expects,' 'may,' 'will,' 'anticipates,' 'estimates,' 'intends,' 'goal,' 'target,' 'commitment,' and other words of similar meaning. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvue Inc. and its affiliates. A list and descriptions of risks, uncertainties, and other factors can be found in Kenvue Inc.'s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 29, 2024, and subsequent Quarterly Reports on Form 10-Q and other filings, available at or on request from Kenvue Inc. Kenvue Inc. and its affiliates undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise. Footnotes: 1 Applies to all Kenvue-owned facilities where Kenvue has operational control, regardless of building type; all leased facilities used for manufacturing and/or research and development; and leased, non-manufacturing and/or non-research and development facilities where the facility is greater than 50,000 square feet and where Kenvue has operational control. The 2020 base year and all subsequent reporting years include all facilities aligned to Kenvue's structure upon separation from Johnson & Johnson in 2023 and do not include any operational or organizational exclusions. 2 The target boundary includes land-related emissions and removals from bioenergy feedstocks. 3 The inventory was compiled in accordance with the World Resources Institute (WRI)/World Business Council for Sustainable Development (WBCSD) (GHG) Protocol – A Corporate Accounting and Reporting Standard (Revised Edition 2013) including the amendment to this protocol, GHG Protocol Scope 2 Guidance (2015). 4 We aim to meet the goal by end of fiscal year and publish the year after. 5 Renewable energy source is an energy source that is capable of being replenished in a short time through ecological cycles or agricultural processes (e.g., biomass, geothermal, hydro, solar, wind). Renewable electricity targets are achieved through a combination of actions, including on-site solar, virtual power purchase agreements (VPPAs), direct power purchase agreements (PPAs), energy attribute certificates (EACs), also known as renewable electricity certificates (RECs), and green retail contracts. 6 Packaging for direct purchases may not include all externally manufactured products. Total weight of plastics packaging is calculated utilizing 2025 Business Plan volume and is not trued up to actual sales. Manual adjustments of <10% were made to 2025 Business Plan volume based on SME judgment to remove materials not assumed to contain plastics. 7 Recyclable, also defined as recycle-ready, is when packaging is designed for collection, sorting, and recycling using end of-life processes, but where collection, sorting and recycling infrastructure may not yet be in place for the packaging to actually be recycled. Best practices of 'designing for recyclability' guidance for plastic-based packaging include the Association of Plastics Recyclers in the U.S. Note: 'Designed for recycling,' 'designed for recyclability,' and 'recycle ready' are also used interchangeably and reflect the same meaning. Recyclability % was assessed using Ellen MacArthur Foundation recycling rate guidelines and Consumer Goods Forum golden design rules guidelines. For pure buy, data assumptions were made on recyclability at brand level. 8 Kenvue defines refillable or reusable packaging as packaging that is designed for either the business or the consumer to put the same type of purchased product back into the original packaging, is designed to be returnable and/or refillable, and accomplishes a minimum number of reuses by being part of a system that enables reuse. 9 Virgin plastic means newly manufactured resin produced from petrochemical feedstock used as the raw material for the manufacture of plastic products and which has never been used or processed before.
Associated Press
26-06-2025
- Business
- Associated Press
Kenvue Releases Second Annual Healthy Lives Mission Report Highlighting Progress in Reducing Emissions and Advancing More Sustainable Product Innovation
Kenvue Inc. (NYSE: KVUE), maker of iconic brands such as Neutrogena®, Listerine®, Aveeno®, and Tylenol®, today released its second Healthy Lives Mission Report. The report shares how Kenvue has helped advance the well-being of both people and planet in 2024, with progress noted across three pillars: Healthy People, Healthy Planet, and Healthy Practice. 'Having some of the most recognizable consumer brands in the world gives us a tremendous opportunity to create a positive impact for the millions of people we touch every day,' said Thibaut Mongon, Chief Executive Officer, Kenvue. 'Whether improving our packaging to be more sustainable, advancing the decarbonization of our operations, or giving back to our communities, our sustainability strategy is helping meet customer and consumer expectations, and deliver everyday care for generations to come.' Since becoming an independent company in 2023, Kenvue has invested in research and development, hired experts in areas like packaging, embedded sustainability into key functions and designed a sustainability strategy purposefully built to meet critical commitments and deliver superior consumer experiences and products. Highlights from the report include: Healthy People: Healthy Planet: Healthy Practice: To read Kenvue's 2024 Healthy Lives Mission Report, visit About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at Cautions Concerning Forward-Looking Statements This media alert contains 'forward-looking statements' as defined in the Private Securities Litigation Reform Act of 1995, including forward-looking statements related to the Healthy Lives Mission and its related goals and commitments. Forward-looking statements may be identified by the use of words such as 'plans, 'expects,' 'may,' 'will,' 'anticipates,' 'estimates,' 'intends,' 'goal,' 'target,' 'commitment,' and other words of similar meaning. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvue Inc. and its affiliates. A list and descriptions of risks, uncertainties, and other factors can be found in Kenvue Inc.'s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 29, 2024, and subsequent Quarterly Reports on Form 10-Q and other filings, available at or on request from Kenvue Inc. Kenvue Inc. and its affiliates undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise. # # # Footnotes:1 Applies to all Kenvue-owned facilities where Kenvue has operational control, regardless of building type; all leased facilities used for manufacturing and/or research and development; and leased, non-manufacturing and/or non-research and development facilities where the facility is greater than 50,000 square feet and where Kenvue has operational control. The 2020 base year and all subsequent reporting years include all facilities aligned to Kenvue's structure upon separation from Johnson & Johnson in 2023 and do not include any operational or organizational exclusions. 2 The target boundary includes land-related emissions and removals from bioenergy feedstocks. 3 The inventory was compiled in accordance with the World Resources Institute (WRI)/World Business Council for Sustainable Development (WBCSD) (GHG) Protocol – A Corporate Accounting and Reporting Standard (Revised Edition 2013) including the amendment to this protocol, GHG Protocol Scope 2 Guidance (2015). 4 We aim to meet the goal by end of fiscal year and publish the year after. 5 Renewable energy source is an energy source that is capable of being replenished in a short time through ecological cycles or agricultural processes (e.g., biomass, geothermal, hydro, solar, wind). Renewable electricity targets are achieved through a combination of actions, including on-site solar, virtual power purchase agreements (VPPAs), direct power purchase agreements (PPAs), energy attribute certificates (EACs), also known as renewable electricity certificates (RECs), and green retail contracts. 6 Packaging for direct purchases may not include all externally manufactured products. Total weight of plastics packaging is calculated utilizing 2025 Business Plan volume and is not trued up to actual sales. Manual adjustments of <10% were made to 2025 Business Plan volume based on SME judgment to remove materials not assumed to contain plastics. 7 Recyclable, also defined as recycle-ready, is when packaging is designed for collection, sorting, and recycling using end of-life processes, but where collection, sorting and recycling infrastructure may not yet be in place for the packaging to actually be recycled. Best practices of 'designing for recyclability' guidance for plastic-based packaging include the Association of Plastics Recyclers in the U.S. Note: 'Designed for recycling,' 'designed for recyclability,' and 'recycle ready' are also used interchangeably and reflect the same meaning. Recyclability % was assessed using Ellen MacArthur Foundation recycling rate guidelines and Consumer Goods Forum golden design rules guidelines. For pure buy, data assumptions were made on recyclability at brand level. 8 Kenvue defines refillable or reusable packaging as packaging that is designed for either the business or the consumer to put the same type of purchased product back into the original packaging, is designed to be returnable and/or refillable, and accomplishes a minimum number of reuses by being part of a system that enables reuse. 9 Virgin plastic means newly manufactured resin produced from petrochemical feedstock used as the raw material for the manufacture of plastic products and which has never been used or processed before. Visit 3BL Media to see more multimedia and stories from Kenvue
Business Wire
02-06-2025
- Business
- Business Wire
Kenvue Debuts on Fortune 500 List
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced it has made the prestigious Fortune 500 list for the first time since becoming a fully independent company. With 2024 full year sales of $15.5 billion, Kenvue is listed at number 281. The company's debut is a testament to the power of its iconic brands and deep commitment to improving the health and well-being of consumers globally through science-backed, insights-led innovation. 'Being named to the Fortune 500 list marks a significant milestone for Kenvue,' said Thibaut Mongon, Chief Executive Officer. 'Recognitions like this validate the hard work and dedication of our Kenvuers, while also further propelling our desire to become the undisputed global leader in consumer health. We are honored to join this elite group of companies and look forward to continuing our journey of growth and impact.' Operating in over 165 countries worldwide, Kenvue is comprised of a curated portfolio of Essential Health, Self Care, and Skin Health & Beauty brands reaching approximately 1.2 billion people daily. Its global workforce of more than 20,000 purpose-led, values-based Kenvuers are driven to make a meaningful impact on the health of people and the planet. By combining the power of science with deep human insights and cutting-edge technology, Kenvue is poised to use its size and scale as a Fortune 500 company to take a leadership role in the wellness revolution - placing its products and solutions at the center of everyday care rituals, today and into the future. Now in its 71st year, the Fortune 500 is Fortune magazine's annual list of the 500 largest U.S. companies ranked by total revenues for their respective fiscal years. The list is compiled using the most recent revenue figures and includes both public and private companies. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at
